- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CFF: CAFFEINE(Non-covalent)
CFF.2: 6 residues within 4Å:- Chain E: F.3756, E.4242, I.4245, W.4714, I.4994, W.5009
4 PLIP interactions:4 interactions with chain E- pi-Stacking: E:W.4714, E:W.4714, E:W.4714, E:W.4714
CFF.11: 6 residues within 4Å:- Chain F: F.3756, E.4242, I.4245, W.4714, I.4994, W.5009
4 PLIP interactions:4 interactions with chain F- pi-Stacking: F:W.4714, F:W.4714, F:W.4714, F:W.4714
CFF.20: 6 residues within 4Å:- Chain G: F.3756, E.4242, I.4245, W.4714, I.4994, W.5009
4 PLIP interactions:4 interactions with chain G- pi-Stacking: G:W.4714, G:W.4714, G:W.4714, G:W.4714
CFF.29: 6 residues within 4Å:- Chain H: F.3756, E.4242, I.4245, W.4714, I.4994, W.5009
4 PLIP interactions:4 interactions with chain H- pi-Stacking: H:W.4714, H:W.4714, H:W.4714, H:W.4714
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.3: 14 residues within 4Å:- Chain E: K.4214, K.4217, R.4218, M.4952, E.4953, K.4955, C.4956, F.4957, I.4958, F.4973, T.4977, H.4981, N.4982, L.4983
13 PLIP interactions:13 interactions with chain E- Hydrogen bonds: E:E.4953, E:F.4957, E:I.4958, E:T.4977, E:T.4977, E:H.4981, E:L.4983
- Salt bridges: E:K.4214, E:K.4214, E:K.4217, E:K.4217, E:K.4217, E:R.4218
ATP.7: 8 residues within 4Å:- Chain E: W.883, R.887, R.898, H.905, C.907, Y.921, W.997, R.1021
9 PLIP interactions:9 interactions with chain E- Hydrogen bonds: E:W.883, E:Y.921, E:W.997, E:R.1021
- Salt bridges: E:R.887, E:R.898, E:H.905, E:H.905, E:R.1021
ATP.12: 14 residues within 4Å:- Chain F: K.4214, K.4217, R.4218, M.4952, E.4953, K.4955, C.4956, F.4957, I.4958, F.4973, T.4977, H.4981, N.4982, L.4983
13 PLIP interactions:13 interactions with chain F- Hydrogen bonds: F:E.4953, F:F.4957, F:I.4958, F:T.4977, F:T.4977, F:H.4981, F:L.4983
- Salt bridges: F:K.4214, F:K.4214, F:K.4217, F:K.4217, F:K.4217, F:R.4218
ATP.16: 8 residues within 4Å:- Chain F: W.883, R.887, R.898, H.905, C.907, Y.921, W.997, R.1021
9 PLIP interactions:9 interactions with chain F- Hydrogen bonds: F:W.883, F:Y.921, F:W.997, F:R.1021
- Salt bridges: F:R.887, F:R.898, F:H.905, F:H.905, F:R.1021
ATP.21: 14 residues within 4Å:- Chain G: K.4214, K.4217, R.4218, M.4952, E.4953, K.4955, C.4956, F.4957, I.4958, F.4973, T.4977, H.4981, N.4982, L.4983
13 PLIP interactions:13 interactions with chain G- Hydrogen bonds: G:E.4953, G:F.4957, G:I.4958, G:T.4977, G:T.4977, G:H.4981, G:L.4983
- Salt bridges: G:K.4214, G:K.4214, G:K.4217, G:K.4217, G:K.4217, G:R.4218
ATP.25: 8 residues within 4Å:- Chain G: W.883, R.887, R.898, H.905, C.907, Y.921, W.997, R.1021
9 PLIP interactions:9 interactions with chain G- Hydrogen bonds: G:W.883, G:Y.921, G:W.997, G:R.1021
- Salt bridges: G:R.887, G:R.898, G:H.905, G:H.905, G:R.1021
ATP.30: 14 residues within 4Å:- Chain H: K.4214, K.4217, R.4218, M.4952, E.4953, K.4955, C.4956, F.4957, I.4958, F.4973, T.4977, H.4981, N.4982, L.4983
13 PLIP interactions:13 interactions with chain H- Hydrogen bonds: H:E.4953, H:F.4957, H:I.4958, H:T.4977, H:T.4977, H:H.4981, H:L.4983
- Salt bridges: H:K.4214, H:K.4214, H:K.4217, H:K.4217, H:K.4217, H:R.4218
ATP.34: 8 residues within 4Å:- Chain H: W.883, R.887, R.898, H.905, C.907, Y.921, W.997, R.1021
9 PLIP interactions:9 interactions with chain H- Hydrogen bonds: H:W.883, H:Y.921, H:W.997, H:R.1021
- Salt bridges: H:R.887, H:R.898, H:H.905, H:H.905, H:R.1021
- 4 x CA: CALCIUM ION(Non-covalent)
CA.4: 3 residues within 4Å:- Chain E: E.3896, E.3970, T.4999
4 PLIP interactions:4 interactions with chain E- Metal complexes: E:E.3896, E:E.3896, E:E.3970, E:T.4999
CA.13: 3 residues within 4Å:- Chain F: E.3896, E.3970, T.4999
4 PLIP interactions:4 interactions with chain F- Metal complexes: F:E.3896, F:E.3896, F:E.3970, F:T.4999
CA.22: 3 residues within 4Å:- Chain G: E.3896, E.3970, T.4999
4 PLIP interactions:4 interactions with chain G- Metal complexes: G:E.3896, G:E.3896, G:E.3970, G:T.4999
CA.31: 3 residues within 4Å:- Chain H: E.3896, E.3970, T.4999
4 PLIP interactions:4 interactions with chain H- Metal complexes: H:E.3896, H:E.3896, H:E.3970, H:T.4999
- 8 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PCW.5: 15 residues within 4Å:- Chain E: V.4845, L.4848, Y.4849, V.4852, N.4855, F.4856, F.4857, Y.4907, Y.4910, V.4913, F.4914, T.4917, F.4921
- Chain H: Y.4628
- Ligands: PCW.33
13 PLIP interactions:13 interactions with chain E- Hydrophobic interactions: E:V.4845, E:L.4848, E:Y.4849, E:Y.4849, E:F.4856, E:F.4856, E:Y.4910, E:Y.4910, E:Y.4910, E:V.4913, E:F.4914, E:F.4921
- Hydrogen bonds: E:Y.4907
PCW.6: 12 residues within 4Å:- Chain E: M.4796, Y.4802, N.4803, F.4805, F.4806, L.4812
- Chain F: L.4848, V.4851, N.4855, F.4856
- Ligands: 01.8, PCW.14
11 PLIP interactions:6 interactions with chain F, 5 interactions with chain E- Hydrophobic interactions: F:L.4848, F:L.4848, F:V.4851, F:N.4855, F:F.4856, F:F.4856, E:F.4805, E:F.4806, E:F.4806, E:L.4812
- Hydrogen bonds: E:N.4803
PCW.14: 15 residues within 4Å:- Chain E: Y.4628
- Chain F: V.4845, L.4848, Y.4849, V.4852, N.4855, F.4856, F.4857, Y.4907, Y.4910, V.4913, F.4914, T.4917, F.4921
- Ligands: PCW.6
13 PLIP interactions:13 interactions with chain F- Hydrophobic interactions: F:V.4845, F:L.4848, F:Y.4849, F:Y.4849, F:F.4856, F:F.4856, F:Y.4910, F:Y.4910, F:Y.4910, F:V.4913, F:F.4914, F:F.4921
- Hydrogen bonds: F:Y.4907
PCW.15: 12 residues within 4Å:- Chain F: M.4796, Y.4802, N.4803, F.4805, F.4806, L.4812
- Chain G: L.4848, V.4851, N.4855, F.4856
- Ligands: 01.17, PCW.23
9 PLIP interactions:5 interactions with chain F, 4 interactions with chain G- Hydrophobic interactions: F:F.4805, F:F.4806, F:F.4806, F:L.4812, G:V.4851, G:N.4855, G:F.4856, G:F.4856
- Hydrogen bonds: F:N.4803
PCW.23: 15 residues within 4Å:- Chain F: Y.4628
- Chain G: V.4845, L.4848, Y.4849, V.4852, N.4855, F.4856, F.4857, Y.4907, Y.4910, V.4913, F.4914, T.4917, F.4921
- Ligands: PCW.15
13 PLIP interactions:13 interactions with chain G- Hydrophobic interactions: G:V.4845, G:L.4848, G:Y.4849, G:Y.4849, G:F.4856, G:F.4856, G:Y.4910, G:Y.4910, G:Y.4910, G:V.4913, G:F.4914, G:F.4921
- Hydrogen bonds: G:Y.4907
PCW.24: 12 residues within 4Å:- Chain G: M.4796, Y.4802, N.4803, F.4805, F.4806, L.4812
- Chain H: L.4848, V.4851, N.4855, F.4856
- Ligands: 01.26, PCW.32
11 PLIP interactions:6 interactions with chain H, 5 interactions with chain G- Hydrophobic interactions: H:L.4848, H:L.4848, H:V.4851, H:N.4855, H:F.4856, H:F.4856, G:F.4805, G:F.4806, G:F.4806, G:L.4812
- Hydrogen bonds: G:N.4803
PCW.32: 15 residues within 4Å:- Chain G: Y.4628
- Chain H: V.4845, L.4848, Y.4849, V.4852, N.4855, F.4856, F.4857, Y.4907, Y.4910, V.4913, F.4914, T.4917, F.4921
- Ligands: PCW.24
13 PLIP interactions:13 interactions with chain H- Hydrophobic interactions: H:V.4845, H:L.4848, H:Y.4849, H:Y.4849, H:F.4856, H:F.4856, H:Y.4910, H:Y.4910, H:Y.4910, H:V.4913, H:F.4914, H:F.4921
- Hydrogen bonds: H:Y.4907
PCW.33: 12 residues within 4Å:- Chain E: L.4848, V.4851, N.4855, F.4856
- Chain H: M.4796, Y.4802, N.4803, F.4805, F.4806, L.4812
- Ligands: PCW.5, 01.35
11 PLIP interactions:5 interactions with chain H, 6 interactions with chain E- Hydrophobic interactions: H:F.4805, H:F.4806, H:F.4806, H:L.4812, E:L.4848, E:L.4848, E:V.4851, E:N.4855, E:F.4856, E:F.4856
- Hydrogen bonds: H:N.4803
- 8 x 01: (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
01.8: 9 residues within 4Å:- Chain E: N.4785, L.4788, Y.4789, W.4792, Y.4793, M.4796, A.4809, L.4812
- Ligands: PCW.6
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:W.4792, E:Y.4793, E:L.4812
- Hydrogen bonds: E:W.4792
01.9: 3 residues within 4Å:- Chain E: L.4909, Y.4910, V.4913
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:Y.4910, E:Y.4910, E:V.4913
- Hydrogen bonds: E:Y.4910
01.17: 9 residues within 4Å:- Chain F: N.4785, L.4788, Y.4789, W.4792, Y.4793, M.4796, A.4809, L.4812
- Ligands: PCW.15
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:W.4792, F:Y.4793, F:L.4812
- Hydrogen bonds: F:W.4792
01.18: 3 residues within 4Å:- Chain F: L.4909, Y.4910, V.4913
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:Y.4910, F:Y.4910, F:V.4913
- Hydrogen bonds: F:Y.4910
01.26: 9 residues within 4Å:- Chain G: N.4785, L.4788, Y.4789, W.4792, Y.4793, M.4796, A.4809, L.4812
- Ligands: PCW.24
4 PLIP interactions:4 interactions with chain G- Hydrophobic interactions: G:W.4792, G:Y.4793, G:L.4812
- Hydrogen bonds: G:W.4792
01.27: 3 residues within 4Å:- Chain G: L.4909, Y.4910, V.4913
4 PLIP interactions:4 interactions with chain G- Hydrophobic interactions: G:Y.4910, G:Y.4910, G:V.4913
- Hydrogen bonds: G:Y.4910
01.35: 9 residues within 4Å:- Chain H: N.4785, L.4788, Y.4789, W.4792, Y.4793, M.4796, A.4809, L.4812
- Ligands: PCW.33
4 PLIP interactions:4 interactions with chain H- Hydrophobic interactions: H:W.4792, H:Y.4793, H:L.4812
- Hydrogen bonds: H:W.4792
01.36: 3 residues within 4Å:- Chain H: L.4909, Y.4910, V.4913
4 PLIP interactions:4 interactions with chain H- Hydrophobic interactions: H:Y.4910, H:Y.4910, H:V.4913
- Hydrogen bonds: H:Y.4910
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Weninger, G., Structural basis for statin-induced skeletal muscle weakness. To Be Published
- Release Date
- 2025-10-08
- Peptides
- Peptidyl-prolyl cis-trans isomerase FKBP1A: ABCD
Ryanodine receptor 1: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
HE
DF
AG
BH
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 4 x CFF: CAFFEINE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 8 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
- 8 x 01: (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Weninger, G., Structural basis for statin-induced skeletal muscle weakness. To Be Published
- Release Date
- 2025-10-08
- Peptides
- Peptidyl-prolyl cis-trans isomerase FKBP1A: ABCD
Ryanodine receptor 1: EFGH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
HE
DF
AG
BH
C - Membrane
-
We predict this structure to be a membrane protein.